Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Oncotarget
|
February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials
Ishwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
JCO Oncology Practice
|
March 21, 2022
Social Media and Professional Development for Oncology Professionals
Anusha Chidharla, Audun Utengen, Deanna J Attai, et al.
JNCI Cancer Spectrum
|
April 27, 2023
Feasibility and acceptability of an online intervention to enhance hopefulness among oncology professionals
Benjamin W Corn, David B Feldman, Ishwaria M Subbiah, et al.
Journal of Patient-Reported Outcomes
|
May 26, 2023
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
Loretta A Williams, Meagan S Whisenant, Tito R Mendoza, et al.
JCO Oncology Practice
|
October 6, 2025
ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States
Erin P Balogh, Laura A Levit, Joseph M Unger, et al.
Elife
|
February 7, 2023
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
Hiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of Geriatric Oncology
|
November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
Ethan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Oncotarget
|
February 9, 2013
Targeted therapy of advanced gallbladder cancer and cholangiocarcinoma with aggressive biology: eliciting early response signals from phase 1 trials
Ishwaria M Subbiah, Vivek Subbiah, Apostolia M Tsimberidou, et al.
Cancers
|
September 19, 2020
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials
Timothy A Lin, Clifton David Fuller, Vivek Verma, et al.
JCO Oncology Practice
|
March 21, 2022
Social Media and Professional Development for Oncology Professionals
Anusha Chidharla, Audun Utengen, Deanna J Attai, et al.
JNCI Cancer Spectrum
|
April 27, 2023
Feasibility and acceptability of an online intervention to enhance hopefulness among oncology professionals
Benjamin W Corn, David B Feldman, Ishwaria M Subbiah, et al.
Journal of Patient-Reported Outcomes
|
May 26, 2023
Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID)
Loretta A Williams, Meagan S Whisenant, Tito R Mendoza, et al.
JCO Oncology Practice
|
October 6, 2025
ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States
Erin P Balogh, Laura A Levit, Joseph M Unger, et al.
Elife
|
February 7, 2023
Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period
Hiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, et al.
Journal of Hematology & Oncology
|
June 12, 2015
STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion
Vivek Subbiah, Caitlin McMahon, Shreyaskumar Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 24, 2020
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Dario Pasalic, Gwendolyn J McGinnis, C David Fuller, et al.
Journal of Geriatric Oncology
|
November 13, 2019
Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials
Ethan B Ludmir, Ishwaria M Subbiah, Walker Mainwaring, et al.
Page
of 6